Looking for long COVID clues in blood
Part of Infections, Lungs & breathing clinical trials.
This study compares the blood of people with ongoing long COVID symptoms to healthy people, to look for differences in immune signals and gut bacteria. It could help find better ways to diagnose or treat long COVID.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You speak English
- You are a patient at Sutter Health
- You either have long COVID (with specific symptoms lasting at least 6 months) or are a healthy person without long COVID
- You do not have certain other serious health conditions or are pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with lasting or complex COVID-19 symptoms who are already in a specialized care program. It aims to better understand and improve recovery after COVID.
This study looks for signs of Long COVID in the blood and gut to better understand the condition. If you have Long COVID or were exposed to the virus without developing it, you may be able to help.
This study follows adults who had COVID-19 to learn how the illness can affect health over the long term. It may help researchers understand lasting symptoms and who is at higher risk, which could improve future care.
This trial studies how your immune system responds in people with Long COVID after a past COVID-19 infection. It may help researchers understand why symptoms linger and how the body’s response could be targeted.
This study looks at how COVID-19 changes your genes, which might explain why some people have long-lasting symptoms. If you join, you'll provide a blood sample, and the results could help us better understand long COVID.
This trial is testing treatments for people with long COVID, which is when symptoms last more than 3 months after a COVID-19 infection. The trial focuses on three specific symptom groups: heart inflammation, cough, or severe fatigue with signs of inflammation. It aims to find if certain immune-modulating therapies can help.
Hear when a new Post-Acute COVID-19 Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.